Ideas That Generate Results

Global Liquid Biopsy Market Outlook to 2023

Global Liquid Biopsy Market Outlook to 2023

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Jan, 2018| No. of Pages : 100

Share |
Please make your selection :
Electronic Access - Single User License
US$ 1800.00
CD-ROM Mail Delivery
US$ 1900.00
Hard Copy Mail Delivery
US$ 1900.00
Electronic Access - Multi-User License
US$ 2500.00
1. Analyst View
2. Research Methodology
3. Liquid Biopsy: An Introduction
4. Market Dynamics
    4.1 Market Drivers
          4.1.1 High Prevalence of Cancer
          4.1.2 Technological Advancements in Personalized Therapies
          4.1.3 Increasing Demand for Minimally Invasive Biopsy Techniques
          4.1.4 Low Cost
          4.1.5 Growing Interest of Venture Capital Firms
    4.2 Market Restraints
          4.2.1 A Less-Defined Regulatory Environment
          4.2.2 Comparatively Low Concentration of Molecular Biomarkers in Body Fluids
          4.2.3 Need for Proper Handling and Storage of the Samples
    4.3 Market Opportunities
          4.3.1 Use of Urine Sample May Witness a Paradigm Shift in Screening and Monitoring Practices
          4.3.2 Exosomes Offer Great Advantages as Source Materials
          4.3.3 Next-Generation Sequencing Offers Significant Opportunity
          4.3.4 Prenatal Screening and Organ Transplantation: Upcoming Applications
          4.3.5 Growing Researches on Cerebrospinal Fluid as Sample Source
     4.4 Industry Trends
           4.4.1 Circulating Tumor Cells: Gaining Potential in Liquid Biopsy
           4.4.2 Strong Preference for ctDNA Among Various Biomarkers
           4.4.3 Blood: The Most Widely Used Sample
5. Global Liquid Biopsy Market Outlook to 2023
6. Commercially Developed Liquid Biopsy Kits
7. Global Liquid Biopsy Market Size by Technology
    7.1 Circulating Tumor Cells (CTCs)
    7.2 Circulating Tumor DNA (ctDNA)
    7.3 Exosomes
8. Global Liquid Biopsy Market Size by Sample Type
    8.1 Blood
    8.2 Urine 
9. Global Liquid Biopsy Market Size by Geography
    9.1 North America
    9.2 Europe
    9.3 Asia
    9.4 Rest of the World (RoW)
10. Pipeline Analysis
11. Key Player Analysis
      11.1 Personal Genome Diagnostics
      11.2 Guardant Health, Inc.
      11.3 Pathway Genomics
      11.4 NeoGenomics Laboratories, Inc.
      11.5 RainDance Technologies (a subsidiary of Bio-Rad Laboratories, Inc.)
      11.6 Trovagene, Inc.
      11.7 Circulogene Theranostics
      11.8 Biocartis
      11.9 Cynvenio Biosystems, Inc.
      11.10 Biocept, Inc.
      11.11 ANGLE plc
      11.12 MDxHealth
      11.13 Clearbridge BioMedics Pte Ltd
      11.14 Exosome Diagnostics, Inc.
      11.15 Foundation Medicine, Inc.
      11.16 Roche Molecular Systems, Inc.
      11.17 Genomic Health
      11.18 Myriad Genetics
      11.19 Thermo Fisher Scientific, Inc.
      11.20 QIAGEN N.V.
12. The Future of Liquid Biopsy
Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.